Rare diseases
Investigational molecules
Locations
Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments
FranceStudy on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis
FranceStudy on ANV600 and Pembrolizumab for Patients with Advanced Solid Tumors
FranceStudy of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health
FranceStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
FranceStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
FranceStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
FranceStudy on Pausing Treatment with Pembrolizumab and Axitinib in Patients with Metastatic Kidney Cancer at Good or Intermediate Risk
FranceStudy of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer
FranceStudy on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib
FranceStudy on the Safety and Effectiveness of Ivosidenib or Enasidenib with Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia with IDH1 or IDH2 Mutations
FranceStudy on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
